PANACEABIO — Panacea Biotec Share News
0.000.00%
Last trade - 00:00- IN₹19.08bn
- IN₹17.91bn
- IN₹6.40bn
Brief: Panacea Biotec Says New GST Demand Order Raised For 70.3 Mln Rupees
Brief: Panacea Biotec Receives Additional Award From Unicef Worth $5.20 Million
India's Panacea Biotec rises on $15 mln order from UNICEF
India Stocks: Indian shares set to open little changed
Brief: Panacea Biotec To Consider Raising Of Funds For Upto $20 Mln
India's Panacea Biotec hits upper circuit on settlement with Sanofi India's unit
India's Panacea Biotec rises on getting loan to expand capacity
India's Panacea Biotec jumps as Phase 3 dengue vaccine trial begins
Brief: Panacea Biotec In Receipt Of Request For Arbitration Filed By Human Vaccine LLC, Russia
Brief: Panacea Biotec Unit Gets USFDA Communication Indicating Inspection As OAI
India's Panacea Biotec up on getting antiviral registration in Germany
Brief: India's Panacea Biotec Posts Sept-Quarter Consol Net Loss After Tax At 82.9 Million Rupees
India's Panacea Biotec falls after US FDA scrutiny
Brief: Panacea Biotec Says Got Notification From International Court Of Arbitration, Paris
Brief: Serum Institute Of India Cuts Stake In Panacea Biotec To 3.06% From 5.24% - Exchange Filing
Brief: Serum Institute Of India Sells 2.39% Stake In Panacea Biotec- Exchange Filing
Indian Immunologicals targets dengue vaccine launch by Jan 2026
Brief: India's Panacea Biotec Posts March-Quarter Consol Net Loss After Tax
Brief: Panacea Biotec Posts Dec-Quarter Consol Net Pat vs Loss